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Effect of vitamin D metabolites on calcitriol degradative
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Effect of vitamin D metabolites on calcitriol degradative enzymes in
renal failure. We have demonstrated that in renal failure calcitriol
degradation is decreased and that administration of vitamin D metabo-
lites increases the degradation. In this study, we measured intestinal 24-
and 26-hydroxylase activities and the effects of chronic infusion (7 days)
of vitamin D metabolites on these enzymes' activities in rats with
experimental renal failure. The enzymatic activity of intestinal 24-
hydroxylase, but not 26-hydroxylase, was significantly lower in renal
failure rats compared to control sham operated rats. Replacement of
calcitriol (3 ng/day) significantly increased 24-hydroxylase activity by
17% in rats with renal failure (P < 0.01), although the activity remained
15% lower than the controls (P < 0.01). Intestinal 26-hydroxylase
activity was not lower in renal failure; however, calcitriol treatment
increased the activity beyond that of normal controls. In contrast,
administration of 25(OH)D3 (600 ng/day) and 24,25(OH)2D3 (1 gJday)
reduced the conversion of calcitriol to I ,24,25(OH)3D3 by more than
50% and to l,25,26(OH)3D3 by more than 38%, respectively. We
conclude that calcitriol increased its own degradation in renal failure by
increasing the enzymatic activities of both 24- and 26-hydroxylase.
However, the mechanisms of increased calcitriol degradation by
25(OH)D3 and 24,25(OH)2D3 in renal failure remain unknown.
In renal failure calcitriol degradation is decreased [II and
administration of vitamin D metabolites, such as calcitriol,
25(OH)D3, and 24,25(OH)2D3, improves the degradation rate
[2, 3]. 24-Hydroxylase is an important degradative enzyme for
calcitriol. Two reasons suggest that the activity of this enzyme
is decreased in renal failure: (1) Uremic plasma contains factors
that suppress this enzymatic activity [4]; (2) The induction of
24-hydroxylase by calcitriol is believed to be a receptor-medi-
ated process and is closely related to calcitriol receptor num-
bers [5]. The lower concentration of receptor in renal failure [6]
may result in decreased 24-hydroxylase activity. Several stud-
ies have demonstrated that calcitriol, 25(OH)D3, and
24,25(OH)2D3, increase calcitriol receptor concentrations in
tissue culture [7] and in rats [8]. These metabolites could raise
24-hydroxylase activity and metabolic degradation of calcitriol
through receptor up-regulation. Therefore, in this experiment
we measured 24- and 26-hydroxylase activities in renal failure
and studied the effects of vitamin D metabolites on these
enzymes' activities in renal failure.
Methods
Intestinal 24- and 26-hydroxylase activities in rats with renal
failure
Male Sprague-Dawley rats weighing 200 g underwent subtotal
nephrectomies (N = 5) under ether anesthesia. One kidney was
removed through flank incision and two-thirds of the other
kidney were removed three days later. Control rats (N =6) had
sham nephrectomies. Animals were pair-fed a regular Purina rat
chow containing 1.0% Ca, 0.8% P, and 4.5 IU per g vitamin D.
Intestinal 24- and 26-hydroxylase activities were measured one
week after sham or subtotal nephrectomies. Plasma concentra-
tions of creatinine, calcitriol, calcium, and phosphorus were
measured at the time of sacrifice.
Effects of calcitriol, 25(OH)D3 and 24,25(OH)2D3 on the
enzymatic activity of 24- and 26-hydroxylase in chronic renal
failure
Since administration of calcitriol, 25(OH)D3 and
24,25(OH)2D3 accelerates the metabolic clearance rate of cal-
citriol [3], we measured the activity of 24- and 26-hydroxylase
in rats with chronic renal failure after they received these
vitamin D metabolites. Male Sprague-Dawley rats weighing 200
g underwent identical subtotal nephrectomies and sham ne-
phrectomies as above. Animals were pair-fed throughout the
studies. Four days after surgery they were divided into five
groups and received either vehicle or vitamin D metabolites.
The doses of vitamin D metabolites used in the present study
were identical to those used in our previous experiments [3].
These doses of vitamin D metabolites have been shown to
accelerate the metabolic clearance of calcitriol without mark-
edly altering calcium and phosphorus metabolism. Intestinal 24-
and 26-hydroxylase activities were measured one week after
they received these metabolites.
Group 1. Five rats underwent sham nephrectomies. They
were infused subcutaneously for seven days with a vehicle for
dissolving vitamin D metabolites (1.25% ethanol in propylene
glycol) by osmotic minipumps implanted subcutaneously be-
tween the scapulae.
Group 2. Five rats had subtotal nephrectomies and received
vehicle infusion using osmotic minipumps as in group 1 animals.
Group 3. Five rats had subtotal nephrectomies and received
3 ng/day of calcitriol delivered by osmotic minipumps. This
dose of calcitriol was equivalent to the difference in calcitriol
509
Received for publication June 23, 1993
and in revised form September 1, 1993
Accepted for publication September 2, 1993
© 1994 by the International Society of Nephrology
510 Pate! et a!: Calcitriol degradative enzymes in RF
production rate between the subtotally nephrectomized rats and
control animals [3].
Group 4. Five rats had subtotal nephrectomies and were
infused subcutaneously for seven days with 600 nglday of
25(OH)D3.
Group 5. Five rats had subtotal nephrectomies and were
infused subcutaneously for seven days with 1 gIday of
24,25(OH)2D3 delivered by osmotic minipumps.
Arterial blood was withdrawn for the measurements of cre-
atinine, calcium, phosphorus and calcitriol at the time of
sacrifice.
Analytical methods
Calcium concentration was measured by atomic absorption
spectrophotometry (model 306; Perkin Elmer, Norwalk, Con-
necticut, USA). The concentration of creatinine and phospho-
rus were measured as described previously [31. Plasma cal-
citriol was measured in duplicate using a radioreceptor assay
according to the method of Reinhardt et al [9] and Hollis [10].
The intra-assay coefficients of variation were 5.4% for low
control (20 pg/mI, N = 6) and 4.7% for high control (100 pg/mI,
N = 6). The inter-assay coefficients of variation were 7% for
low (N = 12) and 4.1% for high control (N = 12).
Measurement of intestinal 24- and 26-hydroxylase activities
(assessed by conversion of calcitriol to 1 ,24,25(OH)3D3 and to
1 ,25,26(OH)3D, respectively), was performed as follows. An-
imals were sacrificed and the first 20 cm of small intestine distal
to the pylorus was removed and rinsed with 20 ml ice-cold
normal saline. 24- and 26-hydroxylase activities were measured
according to previously described methods [11] with modifica-
tion [4]. The mucosa was scraped from the serosa and homog-
enized in ice-cold 0.25 M sucrose solution to yield a 2% wt/vol
homogenate. One ml of the homogenate was placed in a 25 ml
Erlenmeyer flask. To each of the flasks we added 0.5 ml cf
Buffer I (22 m glucose-6-phosphate, 20 m ATP disodium
salt, 160 m nicotinamide, 0.42 m NAD, 0.37 mrvi NADP, 7.5
mM succinate, 0.1 M K2HPO4, pH 7.4) and 0.5 ml of Buffer 11(5
mM MgCI2, 0.1 M KCI, 0.2 U/ml glucose-6-phosphate dehydro-
genase, 0.85 U/ml alcohol dehydrogenase). Vitamin D binding
protein of the homogenates was saturated with 50 M Vitamin
so that calcitriol added to the medium remained free from
protein binding [12], The mixture, open to the atmosphere, was
incubated and agitated (100 cycles/mm) at 37°C. In a prelimi-
nary study, we found that 10 M calcitriol was a minimal
saturating concentration for intestinal generation of 1,24,
25(OH)3D3. This generation was linear up to five minutes (Fig.
1). As for 1 ,25,26(OH)3D3 generation, it was also linear up to
five minutes, but it required more than 20 LM of calcitriol to
achieve the maximal generation of 1 ,25,26(OH)3D3. For the
group of chronic renal failure and sham operated rats without
vitamin D metabolite treatments, six substrate concentrations,
0.5, 1.0, 2.5, 5.0, 7.5, and 10 calcitriol containing 160 fmol
tritiated calcitriol in each sample were used in the study. The
reactions were terminated two minutes alter incubating with the
substrates by the addition of 10 ml methanol:chloroform (2:1).
24- and 26-hydroxylase activities were expressed as the total
generations of 1,24,25(OH)3D3 and 1,25,26(OH)3D3 pmol per
mg of intestinal mucosa in two minutes, respectively. For the
groups of rats treated with vitamin D metabolites, only 10 of
calcitriol containing 160 fmol tritiated calcitriol was used as a
substrate for the study. The reactions were terminated three
minutes alter substrate addition, and 24- and 26-hydroxylase
activities were expressed as the total generations of
1 ,24,25(OH)3D3 and 1 ,25,26(OH)3D3 pmol per mg of intestinal
mucosa in three minutes, respectively. Five micrograms each of
cold 1,24,25(OH)3D3 and l,25,26(OH)3D3 were added to each
flask for subsequent recovery measurements during the extrac-
tion of the trihydroxyvitamin D metabolites. To effect phase
separation, an additional volume of chloroform was added. The
chloroform phase was removed, and the aqueous phase was
re-extracted with an additional 1.5 volumes of chloroform. The
chloroform was evaporated under reduced pressure [13].
The extraction of radiolabeled 1 ,24,25(OH)3D3 and
1 ,25,26(OH)3D3 from incubation medium was identical to that
described previously [4, 13]. Briefly, the reaction was termi-
nated by the addition of methanol:methylene chloride and the
flask contents were decanted into 50 ml separatory tubes. Six
ml of homogenizing buffer and eight ml methylene chloride
were added to each tube. The mixture was vigorously vortexed
for 20 seconds and centrifuged at 200 g for 15 minutes. The
upper aqueous phase was removed and the lower organic phase
containing lipids was aspirated and placed into 15 ml tubes. The
methylene chloride was evaporated with nitrogen gas. The
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Fig. 1. Relationship between the production
of I ,24,25(OH)3D3 and calcitriol concentration
(A) and the time course of I,24.25(OH)3D3
production (B) by intestinal mucosa.
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PC Pc Pp Pcic.tnoi
pg/mimg/dl
Controls (N = 6) 208 4.3 0.54 0.01 9.87 0.08 6.29 0.08 80.8 2.7
Nephrectomy (N =5) 206 6.5 1.15 0.02 9.72 0.12 6.40 0.13 47.6 2.0
P value NS <0.001 NS NS <0.001
Abbreviations are: 'Cr, plasma creatinine; 'Ca, plasma calcium; Ps,, plasma phosphorus; P0i' plasma calcitriol.
Fig. 2. Intestinal 24- (A) and 26-hydroxylase
(B) activities in rats one week after subtotal
nephrectomies (N = 5) and sham operations(N = 6) (pmol/mg intestine was total
generation measured two mm after
incubation). 24-hydroxylase activity was
10 decreased in rats with renal failure, whereas
26-hydroxylase activity was not different
between control (0) and renal failure (I).
(9:1:1) and applied to a Sephadex LH 20 column (0.6cm X 15.5
cm). The column was washed with 18.0 ml of hexane:methanol:
chloroform (9:1:1) and the eluate was discarded. The column
was then washed with 11.0 ml of hexane:methanol:chloroform
(8:2:2). The eluate was collected into 15 ml tube. The hexane:
methanol:chloroform was evaporated under nitrogen gas. The
extract was reconstituted in 0.5 ml 86:14 hexane:isopropanol
and injected into a Zorbax Sil siicic acid Dupont Column
developed in 86:14 hexane:isopropanol. Elution profiles of
vitamin D3, 25(OH)D3, 24,25(OH)2D3, 1 ,25(OH)2D3, 1,24,25
(OH)3D3, and 1,25,26(OH)3D3 were identical to those in previ-
ous reports [13]. The tritiated trihydroxyvitamin D metabolites
were isolated using HPLC, mixed with organic phase scintilla-
tion liquid and counted (Packard Scintillation Counter, model
3255, Packard Instrument, Downers Grove, Illinois, USA). The
tnhydroxyvitamin D metabolites were quantitated by multiply-
ing the ratio of tritiated trihydroxyvitamin D metabolites to
tritiated calcitriol with the amount of cold calcitriol added. It
should be noted that all three hydrogen atoms of C-26 of labeled
calcitriol are tritiated. Therefore, hydroxylation of 1,25(26,27-
3H)(OH)2D3 at the C-26 position releases one 3H. This was
taken into consideration in the calculation of 1 ,25,26(OH)3D3
generation.
All data were expressed as mean SEM. Statistical analysis
was performed using Student t-test and Duncan's multiple
range test. A P value of less than 0.05 was considered signifi-
cant.
Results
Intestinal 24- and 26-hydroxylase activities in rats with renal
failure
Body weight of rats and their plasma concentrations of
creatmine, calcium, phosphorus, and calcitnol are summarized
in Table 1. Plasma concentrations of creatinine were higher in
renal failure rats, whereas plasma concentrations of calcium
and phosphorus were not different between the control rats and
renal failure rats. Plasma calcitriol, however, was significantly
lower in renal failure rats.
Intestinal 24- and 26-hydroxylase activities were measured by
the generations of 1 ,24,25(OH)3D3 and 1 ,25,26(OH)3D3 two
minutes after the addition of various concentrations of substrate
(0.5 to 10 M calcitriol) in each sample. Intestinal 24-hydroxy-
lase activity was significantly lower at each concentration of
substrate in rats with renal failure as shown in Figure 2. In
contrast, intestinal 26-hydroxylase activity was not different
between the two groups of rats (Fig. 2).
Effects of calcitriol, 25(OH)D3 and 24,25(OH)2D3 on the
enzymatic activity of 24- and 26-hydroxylase in chronic renal
failure
Plasma concentrations of creatinine, calcium, phosphorus,
and calcitriol after infusion of vitamin D metabolites are pre-
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Table 2. Effect of vitamin D metabolites on 1 ,24,25(OH)3D3 and 1 ,25,26(OH)3D3 generation in renal failure






1. Sham + vehicle 247 3.2 0.56 0,02 9.44 0.07 7.27 0.16 85.5 1.3 10.9 0.29 33,5 1.12(N = 5)
2. Nephrectomy + 236 2.3 1.25 0.02 9.40 0.07 7.36 0.11 49.0 1.8 7.93 0.20 32.7 0.70
vehicle (N = 5)
3. Nephrectomy + 240 5.2 1.25 0.02 9.72 0,17 7.26 0.07 72.5 1.1 9.27 0.25 40.1 1.12
1,25(OH)2D (N = 5)
4. Nephrectomy + 243 3.3 1.24 0.04 9.58 0.13 7.27 0.21 62.5 1.5 3.35 0.09 15.4 0.59
25(OH)2D3 (N = 5)
5. Nephrectomy + 246 4.6 1.25 0.02 9.60 0.13 7.30 0.20 57.4 1.9 3.90 0.26 19.9 0.46
24,25(OH)2D3 (N = 5)
P value
I vs. 2 NS <0.001 NS NS <0.001 <0.001 NS
1 vs. 3 NS <0.001 NS NS <0.001 <0.001 <0.001
1 vs. 4 NS <0.001 NS NS <0.001 <0.001 <0.001
1 vs. 5 NS <0.001 NS NS <0.001 <0.001 <0.001
2 vs. 3 NS NS NS NS <0.001 <0.001 <0.001
2 vs. 4 NS NS NS NS <0.001 <0.001 <0.001
2 vs. 5 NS NS NS NS <0.001 <0.001 <0.001
Abbreviations are in Table 1.
nephrectomies. Plasma calcium and phosphorus were not dif-
ferent among the control rats, renal failure rats, and renal
failure rats supplemented with vitamin D metabolites. Plasma
calcitriol was significantly lower in rats with renal failure.
Although 3 ng/day of calcitriol supplementation increased
plasma calcitnol levels in renal failure, they were still lower
than those of control rats. Apparently, the supplementation was
inadequate to restore the production rate to a normal level.
Both 25(OH)2D3 and 24,25(OH)2D3 supplementation in rats
with renal failure also increased the plasma concentrations of
calcitriol. However, they remained lower than those of the
controls.
The effects of calcitriol, 3 ng/day, 25(OH)D3, 600 ng/day and
24,25(OH)2D3, 1 pg/day on the activity of 24- and 26-hydroxy-
lase in control rats and renal failure rats are also presented
in Table 2. Intestinal 24- and 26-hydroxylase activities were
measured by the generations of 1,24,25(OH)D3 and 1,25,
26(OH)3D3 three minutes after the addition of 10 M calcitriol.
The results further confirmed that 24-hydroxylase activity, but
not 26-hydroxylase, was lower in rats with renal failure com-
pared to the controls. Supplementation of calcitriol significantly
increased 24-hydroxylase activity by 17% in rats with renal
failure (P < 0.01), but the activity was still 16% lower than that
of the controls. Although intestinal 26-hydroxylase activity was
not lower in renal failure, the activity increased 23% following
calcitriol replacement. In contrast, both 25(OH)D (600 ng/day)
and 24,25(OH)2D3 (1 pg/day) reduced the conversion of cal-
citriol to 1,24,25(OH)3D3 by more than 50% and to
1 ,25,26(OH)3D3 by more than 38%, respectively.
Discussion
We have demonstrated that the degradation of calcitriol is
decreased in renal failure [1] and that decreased 24-hydroxylase
activity could be responsible for the lower calcitriol degradation
rate [4]. The expression of calcitriol induced 24-hydroxylase
activity is believed to be a classical steroid hormone action
mediated through its receptor [5, 7, 14]. It is proposed that the
calcitriol receptor interacts with nuclear chromatin of target
organs and activates the transcription of specific genes to
produce 24-hydroxylase [15, 16]. This enzyme is important in
modulating the biological action of calcitriol. It regulates cal-
citriol degradation and limits its receptor up-regulation and
cellular responsiveness to calcitriol [17]. There are several
reasons to suggest that 24-hydroxylase activity is decreased in
renal failure. (1) Decreased calcitriol production in renal failure
[1] could result in lower 24-hydroxylase activity [15]. (2) Lower
receptor number in renal failure [6] may diminish the biological
response to calcitriol and reduce the synthesis of 24-hydroxy-
lase [5]. (3) In renal failure plasma contains factors that inhibit
24-hydroxylase activity [4].
Previous studies have indicated that vitamin D3 increases
intestinal calcitriol receptor concentration [18]. Calcitriol also
increase its receptor numbers in rat intestine [6], rat osteosar-
coma cells [19], LLC-PK1 cells [7] and human skin fibroblasts
[20]. Further, 25(OH)D3 and 24,25(OH)2D3 increase calcitriol
receptor in tissue culture [20, 21]. These observations suggest
that regulation of receptor may be a general property of vitamin
D metabolites and not necessarily restricted to a particular
organ. Since vitamin D metabolites accelerate calcitriol degra-
dation in renal failure [2, 3], these metabolites could increase
24-hydroxylase activity through receptor up-regulation.
In this study, we found that the activity of intestinal 24-
hydroxylase was indeed lower in rats with renal failure com-
pared to control sham operated rats (Fig. 2). Replacement of
calcitriol to renal failure rats increased the activity of 24-
hydroxylase, though the activity was still lower than the con-
trols. In an unpublished observation, we found that administra-
tion of 3 nglday of calcitriol for one week in rats with a similar
degree of renal insufficiency (average plasma creatinine, 1.27
mg/dl) significantly increased intestinal calcitriol receptor con-
centration to a level 12% greater than that of sham operated
control rats, even though their plasma calcitriol levels were
lower than the sham controls. Therefore, the failure to normal-
ize the activity of 24-hydroxylase could be due to either an
inadequate replacement dose of calcitriol or the presence of
uremic toxins [41 rather than a lower receptor concentration.
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However, our previous study showed that induction of 24-
hydroxylase with a pharmacological dose of calcitriol (100 ng)
remains inhibited in normal rats infused with uremic ultrafiltrate
[4], suggesting that it requires a higher dose of calcitriol to
normalize 24-hydroxylase in the presence of uremic plasma.
Therefore, normalizing plasma calcitriol levels in renal failure
may not necessarily correct 24-hydroxylase activity. Although
the induction of 24-hydroxylase is thought to be a receptor
mediated event, a recent study showed that calcitriol is also
capable of inducing 24-hydroxylase activity in a receptor-
deficient cultured monkey kidney cell line [22].
While calcitriol up-regulates its receptor [6] and the enzy-
matic activity of 26-hydroxylase in normal rats [4], 26-hydrox-
ylase activity has not been shown to be linked to receptor
concentrations. In this study, 26-hydroxylase activity in renal
failure was not decreased despite a lower intestinal calcitriol
receptor concentration [6]. Calcitriol supplementation further
significantly increased the activity of this enzyme, though it is
not clear how supplementation enhanced the activity beyond
that of the controls.
In contrast, 25(OH)D3 markedly suppressed, rather than
activated, 24-hydroxylase activity, even though it increased
metabolic clearance of calcitriol [2, 3]. The large dose of
25(OH)D3 given to these animals could raise the tissue content
of 25(OH)D3, thereby competing with calcitriol for 24-hydrox-
ylase in vitro and reducing the generation of l,24,25(OH)3D3.
This is unlikely as we have previously shown that these animals
were capable of degrading approximately 1.7 pg/day of
25(OH)D3 [2]. Therefore, the intestinal tissue content of
25(OH)D3 was probably very low compared to calcitriol added
to the incubation medium (8 jsg). Supplementation of 25(OH)D3
600 nglday for seven days to renal failure rats increased
intestinal receptor concentration by 22% (unpublished observa-
tion). However, the change in receptor concentration did not
appear to increase 24-hydroxylase activity.
24,25(OH)2D3 also increases the metabolic clearance rate of
calcitriol in renal failure [3], but it reduced the activity of
24-hydroxylase. Although 24,25(OH)2D3 increased receptor
level in tissue culture [20, 21], infusion of this metabolite 1
pg/day for seven days did not increase intestinal receptor
concentration in rats with renal failure (unpublished observa-
tion). 24,25(OH)2D3 may suppress parathyroid hormone in vivo
[23] and in vitro [24]. However, suppression of parathyroid
hormone stimulates, rather than inhibits, 24-hydroxylase [25].
Although 26-hydroxylase activity was not lower in renal
failure, administration of 25(OH)D3 and 24,25(OH)2D3 signifi-
cantly reduced the activity of this enzyme. The reason for the
suppression is not clear.
In mild renal failure, supplementation of 25(OH)D3 or
24,25(OH)2D3 reduces plasma calcitriol concentration by in-
creasing metabolic degradation of calcitriol [3, 26]. The in-
creased calcitriol degradation is probably due to activation of
enzymes other than 24- and 26-hydroxylase. In severe renal
insufficiency, administration of 25(OH)D3 increases plasma
calcitriol concentration primarily by raising substrate concen-
tration [2, 27, 28]. However, the reason for increased plasma
level of calcitriol following 24,25(OH)2D3 administration in the
present study is not clear. Perhaps 24,25(OH)2D3 suppresses
metabolic clearance of calcitriol in severe renal failure. It
should be noted, however, that the clearance rate is increased
in mild renal insufficiency following 24,25(OH)2D3 supplemen-
tation [3].
In summary, the activity of 24-hydroxylase, but not 26-
hydroxylase, is decreased in renal failure. The lower enzymatic
activity could be partly responsible for the decreased degrada-
tion of calcitriol in renal failure. In our previous study, cal-
citriol, 25(OH)D3, and 24,25(OH)2D3 significantly accelerate
the metabolic clearance rate of calcitriol in renal failure [2, 3].
While the activation of 24- and 26-hydroxylase activities by
calcitriol could account for the improvement in metabolic
clearance of calcitriol, the increased metabolic clearance rate of
calcitriol following the administration of 25(OH)D3 and
24,25(OH)2D3 must involve enzymes other than 24- and 26-
hydroxylase, for these metabolites suppress these degradative
enzymes.
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